Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL). Robaeys G, et al. Among authors: bourgeois n, bourgeois s. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):38-45. Acta Gastroenterol Belg. 2005. PMID: 15832586 Review. No abstract available.
Hepatitis C: screening, treatment and prevention practical guidelines.
Michielsen P, Brenard R, Bourgeois N, De Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Nevens F, Reynaert H, Robaeys G, Sprengers D, Van Vlierberghe H; Steering Committee Belgian Association for the Study of the Liver. Michielsen P, et al. Among authors: bourgeois n. Acta Gastroenterol Belg. 2003 Jan-Mar;66(1):15-9. Acta Gastroenterol Belg. 2003. PMID: 12812144 No abstract available.
Risk factors for hepatitis C: past, present and future.
Delwaide J, Bourgeois N, Colle I, Robaeys G. Delwaide J, et al. Among authors: bourgeois n. Acta Gastroenterol Belg. 2002 Apr-Jun;65(2):87-9. Acta Gastroenterol Belg. 2002. PMID: 12148445 Review.
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.
Van Vlierberghe H, Leroux-Roels G, Adler M, Bourgeois N, Nevens F, Horsmans Y, Brouwer J, Colle I, Delwaide J, Brenard R, Bastens B, Henrion J, de Vries RA, de Galocsy C, Michielsen P, Robaeys G, Bruckers L. Van Vlierberghe H, et al. Among authors: bourgeois n. J Viral Hepat. 2003 Nov;10(6):460-6. doi: 10.1046/j.1365-2893.2003.00466.x. J Viral Hepat. 2003. PMID: 14633181 Clinical Trial.
A pilot observational survey of hepatitis C in Belgium.
De Maeght S, Henrion J, Bourgeois N, de Galocsy C, Langlet P, Michielsen P, Reynaert H, Robaeys G, Sprengers D, Orlent H, Adler M. De Maeght S, et al. Among authors: bourgeois n. Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):4-8. Acta Gastroenterol Belg. 2008. PMID: 18396742
Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
Horsmans Y, Colle I, Van Vlierberghe H, Langlet P, Adler M, Bourgeois N, Brenard R, Michielsen P, Goossens A, Bruckers L; Belgian Assocation for the Study of the Liver. Horsmans Y, et al. Among authors: bourgeois n. Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):293-7. Acta Gastroenterol Belg. 2008. PMID: 19198574 Clinical Trial.
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Delwaide J, Bourgeois N, Gérard C, De Maeght S, Mokaddem F, Wain E, Bastens B, Fevery J, Géhénot M, Le Moine O, Martinet JP, Robaeys G, Servais B, Van Gossum M, Van Vlierberghe H; Belgian Association for the Study of the Liver (BASL). Delwaide J, et al. Among authors: bourgeois n. Aliment Pharmacol Ther. 2004 Jul 1;20(1):15-22. doi: 10.1111/j.1365-2036.2004.02023.x. Aliment Pharmacol Ther. 2004. PMID: 15225166 Free article. Clinical Trial.
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Brouwer JT, Nevens F, Bekkering FC, Bourgeois N, Van Vlierberghe H, Weegink CJ, Lefebvre V, Van Hattum J, Henrion J, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group On Treatment Of Chronic Hepatitis C. Brouwer JT, et al. Among authors: bourgeois n. J Hepatol. 2004 Apr;40(4):689-95. doi: 10.1016/j.jhep.2003.12.017. J Hepatol. 2004. PMID: 15030987 Clinical Trial.
244 results